Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has provided an announcement.
China NT Pharma Group Company Limited, a Cayman Islands-incorporated pharmaceutical group listed on the Hong Kong Stock Exchange (stock code 1011), has a board structure that includes executive, non-executive, and independent non-executive directors. This diversified board composition underscores the company’s emphasis on corporate governance and oversight across its subsidiaries and operations.
The company has scheduled a board meeting for March 31, 2026, to approve its annual results for the financial year ended December 31, 2025, and to consider recommending a final dividend. The timing of the meeting signals that shareholders and investors can soon expect clarity on the group’s financial performance and potential cash returns, developments that may influence market perceptions of its profitability and capital allocation.
The most recent analyst rating on (HK:1011) stock is a Hold with a HK$0.76 price target. To see the full list of analyst forecasts on China NT Pharma Group Co., Ltd. stock, see the HK:1011 Stock Forecast page.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Company Limited is a Cayman Islands-incorporated company listed in Hong Kong under stock code 1011. It operates in the pharmaceutical sector through a group structure that includes various subsidiaries, with a board comprising executive, non-executive, and independent non-executive directors overseeing its governance and strategic direction.
The company’s leadership includes Chairman Ng Tit and executive director Ms. Ng, Anna Ching Mei, alongside non-executive and independent non-executive directors such as Dr. Qian Wei, Ms. Chin Yu, Mr. Yu Tze Shan Hailson, Dr. Zhao Yubiao, and Mr. Ng Ming Kwan, reflecting a diversified governance structure aimed at balancing management and independent oversight.
Average Trading Volume: 356,467
Technical Sentiment Signal: Hold
Current Market Cap: HK$498.9M
For a thorough assessment of 1011 stock, go to TipRanks’ Stock Analysis page.